Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | TRN | RLX |
|---|---|---|
| Price | $26.39 | $1.72 |
| Change today | ▲ 1.00% | ▲ 0.58% |
| Market cap | $2.10B | $2.10B |
| Return, 3 months | -21.6% | -9.5% |
| Return, year to date | +2.7% | -26.2% |
| Return, 1 year | -1.8% | -31.2% |
| P/E (TTM) | 6.4 | 15.5 |
| P/B | 1.8 | 0.9 |
| P/E percentile vs own 5y | 8th | 22nd |
| Dividend yield | 4.62% | 6.57% |
| Revenue growth (YoY, latest qtr) | – | +15.5% |
| Net profit growth (YoY) | – | +1.6% |
| Gross margin | – | 39.0% |
| Operating margin | – | 14.2% |
| Net margin | – | 24.2% |
| Return on equity | – | – |
| Analyst target vs. price | – | – |
| Analyst buy share | – | – |
| RSI (14) | 33 | 44 |
| 30-day volatility | 21.8% | 22.8% |
| Max drawdown, 1 year | -32.9% | -36.4% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | – | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
